HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marie Hélène Metz-Boutigue Selected Research

chromogranin A (344-358)

5/2021Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marie Hélène Metz-Boutigue Research Topics

Disease

2Infections
05/2021 - 01/2015
1Sepsis (Septicemia)
05/2021
1Inflammation (Inflammations)
05/2021

Drug/Important Bio-Agent (IBA)

2Peptides (Polypeptides)IBA
05/2021 - 01/2015
1LipopolysaccharidesIBA
05/2021
1Messenger RNA (mRNA)IBA
05/2021
1Interleukin-6 (Interleukin 6)IBA
05/2021
1Chromogranin AIBA
05/2021
1chromogranin A (344-358)IBA
05/2021
1p38 Mitogen-Activated Protein KinasesIBA
05/2021
1Toll-Like Receptor 4IBA
05/2021
1HydrogelsIBA
01/2015